Fox Run Management, L.L.C. Axsome Therapeutics, Inc. Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 6,119 shares of AXSM stock, worth $745,967. This represents 0.1% of its overall portfolio holdings.
Number of Shares
6,119Holding current value
$745,967% of portfolio
0.1%Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$494 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$402 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$179 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$169 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.23B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...